等待开盘 05-19 09:30:00 美东时间
-3.040
-3.57%
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从15美元升至35美元;韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从36美元升至37美元
05-11 15:43
UBS analyst Joshua Spector maintains Solstice Advanced Mat (NASDAQ:SOLS) with a Neutral and raises the price target from $87 to $88.
05-09 05:39
华盛资讯5月7日讯,Solstice Advanced Materials, Inc.公布2026财年Q1业绩,公司Q1营收9.91亿美元,同比增长10.5%,归母净利润0.85亿美元,同比下滑36.6%。
05-07 10:39
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Solstice Advanced Mat (NASDAQ:SOLS) released first-quarter financial results an...
05-06 21:24
华盛资讯5月6日讯,Solstice Advanced Materials, Inc.公布2026财年Q1业绩,公司Q1营收9.91亿美元,同比增长10.5%,归母净利润0.85亿美元,同比下滑36.6%。
05-06 19:05
Solstice Advanced Mat (NASDAQ:SOLS) sees Q2 sales of $1.060 billion-$1.100 billion vs $1.052 billion analyst estimate.
05-06 18:23
Solstice Advanced Mat (NASDAQ:SOLS) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.61 by 1.61 percent. The company reported quarterly sales of $991.000 million which beat
05-06 18:22
Partnership with the only supplier of domestically produced commercial uranium hexafluoride (UF₆) in the United States marks a pivotal fuel cycle milestone as Hadron advances toward the GigCapital7 shareholder vote
04-30 20:07
MORRIS PLAINS, N.J., April 27, 2026 /PRNewswire/ -- Solstice Advanced Materials (NASDAQ: SOLS), today announced that its Board of Directors has declared a regular quarterly dividend payment ...
04-27 19:00